Key Bridge Marriott, 1401 Lee Highway, Arlington, Virginia
An Urgent Message from the WALT President
Our hearts and thoughts go out to the people who have been affected by this unprecedented event and we appreciate the PBM practitioners, healthcare workers, local communities, and governments around the world who are on the front line working to contain this coronavirus. I write to you with two important updates.
First, we are vigilantly monitoring the COVID-19 situation and directives from the World Health Organization (WHO), the Centers for Disease Control and Prevention (CDC), and local health agencies for the latest developments and guidance. The joint NAALT-WALT 2020 meeting in Washington DC in Aug 4-6th 2020 is currently still planned. The program committee is poised to make a final decision in 1st week May as we remain optimistic this crisis will resolve over the next few weeks with the tremendous, impressive global efforts.
Second, we have been receiving several requests to showcase the possible benefits of PBM treatments in this current health crisis. Many of us have clinical and, perhaps personal experiences with PBM treatment have clearly noted its ability to improve anti-viral response and host immunity showcasing the potential utility of this treatment in the current health crisis. Nonetheless, as far as we are aware there have been no direct, controlled studies to date on the Covid-19 specifically. I urge each and every one of you to be diligent in outlining the ‘broader’ PBM evidences and be very careful of specific claims that will – in the long run – be detrimental to the integrity and reputation of the field.
On behalf of your WALT family, I hope you all take suitable precautions as you are on the frontlines as PBM practitioners or advisors to Covid-19 patients and exposed colleagues. We wish you and all your dear ones good health. We hope to meet in Arlington this August.
Yours sincerely, Praveen Arany President
Share this page with friends and colleagues:
NAALT-WALT 2020 Conference
1. Plenary sessions: Mornings on Thursday-Friday, August 6th-7th
Taking PBM to Mainstream Medicine
National Coverage Determinations– a major roadblock to PBM adoption. Negative coverage has had significant impact on acceptance of PBM what do we need to do to change this?
FDA regulatory – What is needed to make meaningful new claims – (as opposed to current 510K claims), process, clinical trials, options based on new regulations?
What evidence do we have for PBM and how do we convince regulators of its validity? Focus on Pain and Tissue repair
Cost effectiveness of PBM
Integration of PBM into clinical treatment pathways
What’s the roadmap for mainstream adoption of PBM?
PBM and Pain Management with a view on the opioid crisis
Where are we really at in the opioid crisis – have we just shifted it to the street?
What is the evidence and cost effectiveness for PBM in pain management
Acute treatment for prevention of the development of chronic pain and addiction – Stop it before it starts!
NAALT’s Commercial Membership Program establishes a new Commercial Partner Advisory Board position, providing an opportunity for the PBM industry to participate with NAALT in a synergistic manner that complements NAALT’s clinical practice and research agenda.
Platinum – Advisory Board position (see Sponsorship Opportunities)
Exhibitor positioning and priority
Access to advertising, banners and discounted membership lists
Platinum, Gold, and Silver positions are limited
Commercial members will meet at the NAALT Annual Meeting to provide input to the Advisory Board position
Function and Objectives:
Providing input as to opportunistic areas of research, including the industry funding of grants for research projects
Focus and development of reimbursement strategies for obtaining CMS payment on National Coverage Determinations (NCD)
Providing input to the NAALT Board of Directors relative to meetings, exhibitions and other opportunities for commercial members to meet and present their products and ideas to NAALT membership
Participating in Lobbying activities to promote PBM
Having access to the latest reimbursement and payment effective for PBM therapies
For more information, and contact NAALT President Terry Baker MD directly with any questions (firstname.lastname@example.org).